• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统性红斑狼疮相关肺动脉高压的临床特征及独立预测因素。

Clinical features and independent predictors of pulmonary arterial hypertension in systemic lupus erythematosus.

机构信息

Department of Rheumatology and Clinical Immunology, The First Affiliated Hospital of Sun Yat-Sen University, No. 58, Zhongshan 2nd Road, 510080, Guangzhou, China.

出版信息

Rheumatol Int. 2012 Jun;32(6):1727-31. doi: 10.1007/s00296-011-1880-4. Epub 2011 Mar 25.

DOI:10.1007/s00296-011-1880-4
PMID:21437686
Abstract

Pulmonary arterial hypertension (PAH) is a devastating complication of systemic lupus erythematosus (SLE). We aim to estimate the putative predictors contributing to early identification of PAH, thus improve appropriate medical intervention and a better prognosis. A retrospective case-control study was conducted. Forty-one SLE patients with PAH and 106 SLE patients without PAH were enrolled. Demographic variables, clinical features, and laboratory data were compared between the two groups. Univariate and multivariate logistic regression models were used to examine the predictors contributing to PAH in SLE. Serositis, Raynaud's phenomenon, high disease activity, anticardiolipin antibodies, and anti-U1RNP were significantly associated with SLE-PAH. Univariate and multivariate analysis showed that Raynaud's phenomenon, anticardiolipin antibodies, and anti-U1RNP were independent predictors of PAH in SLE. This study highlighted the clinical pattern of SLE-PAH patients, and underlined the leading predictors of PAH development among patients with SLE. Routine echocardiography is recommended in SLE patients with the independent predictors mentioned above.

摘要

特发性肺动脉高压(PAH)是系统性红斑狼疮(SLE)的一种严重并发症。我们旨在评估可能有助于早期识别 PAH 的预测因素,从而改善适当的医疗干预和预后。进行了一项回顾性病例对照研究。共纳入 41 例 PAH 的 SLE 患者和 106 例无 PAH 的 SLE 患者。比较两组之间的人口统计学变量、临床特征和实验室数据。使用单因素和多因素逻辑回归模型来检查 SLE 中导致 PAH 的预测因素。胸膜炎、雷诺现象、高疾病活动度、抗心磷脂抗体和抗 U1RNP 与 SLE-PAH 显著相关。单因素和多因素分析表明,雷诺现象、抗心磷脂抗体和抗 U1RNP 是 SLE 中 PAH 的独立预测因素。本研究强调了 SLE-PAH 患者的临床模式,并强调了 SLE 患者中 PAH 发展的主要预测因素。建议对具有上述独立预测因素的 SLE 患者进行常规超声心动图检查。

相似文献

1
Clinical features and independent predictors of pulmonary arterial hypertension in systemic lupus erythematosus.系统性红斑狼疮相关肺动脉高压的临床特征及独立预测因素。
Rheumatol Int. 2012 Jun;32(6):1727-31. doi: 10.1007/s00296-011-1880-4. Epub 2011 Mar 25.
2
Pulmonary arterial hypertension in systemic lupus erythematosus based on a CSTAR-PAH study: Baseline characteristics and risk factors.基于 CSTAR-PAH 研究的系统性红斑狼疮相关肺动脉高压:基线特征和危险因素。
Int J Rheum Dis. 2019 May;22(5):921-928. doi: 10.1111/1756-185X.13478. Epub 2019 Feb 11.
3
Risk factors of pulmonary arterial hypertension in patients with systemic lupus erythematosus: A meta-analysis.系统性红斑狼疮患者肺动脉高压的危险因素:荟萃分析。
Lupus. 2023 Oct;32(11):1310-1319. doi: 10.1177/09612033231202398. Epub 2023 Sep 12.
4
Chinese SLE Treatment and Research group (CSTAR) registry: II. Prevalence and risk factors of pulmonary arterial hypertension in Chinese patients with systemic lupus erythematosus.中国系统性红斑狼疮治疗与研究协作组(CSTAR)注册研究:二、中国系统性红斑狼疮患者肺动脉高压的患病率及危险因素
Lupus. 2014 Sep;23(10):1085-91. doi: 10.1177/0961203314527366. Epub 2014 Mar 20.
5
Characteristics of exercise capacity in female systemic lupus erythematosus associated pulmonary arterial hypertension patients.女性系统性红斑狼疮相关肺动脉高压患者的运动能力特征
BMC Cardiovasc Disord. 2018 Mar 23;18(1):56. doi: 10.1186/s12872-018-0783-7.
6
Risk factors of systemic lupus erythematosus patients with pulmonary arterial hypertension: A systematic review and meta-analysis.系统性红斑狼疮合并肺动脉高压患者的发病危险因素:系统评价和荟萃分析。
Medicine (Baltimore). 2023 Dec 22;102(51):e36654. doi: 10.1097/MD.0000000000036654.
7
Pulmonary arterial hypertension in systemic lupus erythematosus: current status and future direction.系统性红斑狼疮中的肺动脉高压:现状与未来方向
Clin Dev Immunol. 2012;2012:854941. doi: 10.1155/2012/854941. Epub 2012 Mar 22.
8
Nailfold capillaroscopy as a risk factor for pulmonary arterial hypertension in systemic lupus erythematosus patients.甲襞毛细血管显微镜检查作为系统性红斑狼疮患者肺动脉高压的一个危险因素。
Adv Rheumatol. 2019 Jan 6;59(1):1. doi: 10.1186/s42358-018-0045-5.
9
Pulmonary hypertension on systemic sclerosis-lupus erythematosus overlap syndrome.系统性硬化症-红斑狼疮重叠综合征中的肺动脉高压
Ann Cardiol Angeiol (Paris). 2019 Oct;68(4):221-225. doi: 10.1016/j.ancard.2018.10.012. Epub 2019 Jan 23.
10
Features associated with pulmonary arterial hypertension in Chinese hospitalized systemic lupus erythematosus patients.与中国系统性红斑狼疮住院患者肺动脉高压相关的特征。
Clin Rheumatol. 2018 Jun;37(6):1547-1553. doi: 10.1007/s10067-018-4056-8. Epub 2018 Mar 8.

引用本文的文献

1
Pulmonary arterial hypertension in systemic lupus erythematosus: identification of risk factors and haemodynamics characteristics in a multicentre retrospective cohort.系统性红斑狼疮中的肺动脉高压:多中心回顾性队列研究中危险因素及血流动力学特征的识别
Lupus Sci Med. 2025 Jun 12;12(1):e001471. doi: 10.1136/lupus-2024-001471.
2
Cardiac Abnormalities in Relation to the Disease Activity Index Among Systemic Lupus Erythematosus Patients in a Tertiary Hospital: A Cross-Sectional Study.三级医院系统性红斑狼疮患者心脏异常与疾病活动指数的关系:一项横断面研究
Cureus. 2023 Nov 27;15(11):e49495. doi: 10.7759/cureus.49495. eCollection 2023 Nov.
3

本文引用的文献

1
Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype.从 REVEAL 研究中对结缔组织病相关肺动脉高压的特征分析:确定系统性硬化症为一种独特表型。
Chest. 2010 Dec;138(6):1383-94. doi: 10.1378/chest.10-0260. Epub 2010 May 27.
2
Advances in the treatment of Raynaud's phenomenon.雷诺现象治疗的进展。
Vasc Health Risk Manag. 2010 Mar 24;6:167-77. doi: 10.2147/vhrm.s4551.
3
Pulmonary hypertension in systemic lupus erythematosus: relationship with antiphospholipid antibodies and severe disease outcome.
Risk Factors for Pulmonary Arterial Hypertension in Patients With Systemic Lupus Erythematosus: A Systematic Review and Expert Consensus.
系统性红斑狼疮患者肺动脉高压的危险因素:一项系统评价与专家共识
ACR Open Rheumatol. 2023 Dec;5(12):663-676. doi: 10.1002/acr2.11611. Epub 2023 Oct 4.
4
Pulmonary hypertension in Behçet's disease: echocardiographic screening and multidisciplinary approach.Behçet 病相关肺动脉高压:超声心动图筛查与多学科方法。
Turk J Med Sci. 2023 Apr;53(2):563-571. doi: 10.55730/1300-0144.5617. Epub 2023 Apr 19.
5
Pulmonary Arterial Hypertension (PAH) as the Initial Manifestation of Systematic Lupus Erythematosus (SLE): A Rare Presentation.肺动脉高压作为系统性红斑狼疮(SLE)的初始表现:一种罕见的情况。
Cureus. 2023 May 22;15(5):e39359. doi: 10.7759/cureus.39359. eCollection 2023 May.
6
Systemic Lupus Erythematosus and Pulmonary Hypertension.系统性红斑狼疮与肺动脉高压。
Int J Mol Sci. 2023 Mar 7;24(6):5085. doi: 10.3390/ijms24065085.
7
Risk of systemic lupus erythematosus flares according to autoantibody positivity at the time of diagnosis.根据诊断时自身抗体阳性情况评估系统性红斑狼疮发作风险。
Sci Rep. 2023 Feb 21;13(1):3068. doi: 10.1038/s41598-023-29772-w.
8
The Role of Anti-U1 RNP Antibody in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis.抗U1核糖核蛋白抗体在结缔组织病相关肺动脉高压中的作用:一项系统评价和荟萃分析
J Clin Med. 2022 Dec 20;12(1):13. doi: 10.3390/jcm12010013.
9
Systemic Lupus Erythematosus and Lung Involvement: A Comprehensive Review.系统性红斑狼疮与肺部受累:综述
J Clin Med. 2022 Nov 13;11(22):6714. doi: 10.3390/jcm11226714.
10
Decreased low-density lipoprotein and the presence of pulmonary arterial hypertension among newly diagnosed drug-naïve patients with systemic lupus erythematosus: D-dimer as a mediator.初诊未用药的系统性红斑狼疮患者中低密度脂蛋白降低与肺动脉高压的存在:D-二聚体作为一种介质
Exp Ther Med. 2022 Jul 27;24(3):595. doi: 10.3892/etm.2022.11531. eCollection 2022 Sep.
系统性红斑狼疮中的肺动脉高压:与抗磷脂抗体和严重疾病结局的关系。
Rheumatol Int. 2011 Feb;31(2):183-9. doi: 10.1007/s00296-009-1255-2. Epub 2009 Dec 11.
4
Vasculopathy and pulmonary arterial hypertension.血管病变与肺动脉高压。
Rheumatology (Oxford). 2009 Jun;48 Suppl 3:iii54-7. doi: 10.1093/rheumatology/ken484.
5
Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era.现代治疗时代的结缔组织病相关肺动脉高压
Am J Respir Crit Care Med. 2009 Jan 15;179(2):151-7. doi: 10.1164/rccm.200806-953OC. Epub 2008 Oct 17.
6
[Anticoagulation in pulmonary arterial hypertension].[肺动脉高压中的抗凝治疗]
Hamostaseologie. 2008 Oct;28(4):225-30.
7
Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases.狼疮和混合性结缔组织病相关肺动脉高压的免疫抑制治疗:23例回顾性分析
Arthritis Rheum. 2008 Feb;58(2):521-31. doi: 10.1002/art.23303.
8
Pulmonary hypertension, antiphospholipid antibodies, and syndromes.
Clin Rev Allergy Immunol. 2007 Apr;32(2):153-8. doi: 10.1007/s12016-007-0012-0.
9
Raynaud's phenomenon is correlated with elevated systolic pulmonary arterial pressure in patients with systemic lupus erythematosus.雷诺现象与系统性红斑狼疮患者的收缩期肺动脉压升高相关。
Lupus. 2007;16(7):505-8. doi: 10.1177/0961203307080629.
10
Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension.结缔组织病相关肺动脉高压的免疫抑制治疗
Chest. 2006 Jul;130(1):182-9. doi: 10.1378/chest.130.1.182.